EUVIMEDEUVIMED entdecken
Open Access · CC0

The impact of apolipoprotein E, type ∊4 allele on Alzheimer’s disease pathological biomarkers: a comprehensive post-mortem pilot-analysis

Ziyu Wan iD, Tao Ma iD

PLOS ONE · 2025

DOI: 10.1371/journal.pone.0303486 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2025. Verfasst von Ziyu Wan und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Gerontology and Geriatric Medicine, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Apolipoprotein E4. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC0). Gefördert von: NIA NIH HHS, National Institute on Aging.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The apolipoprotein E type ∊4 allele (ApoE4) is known as the strongest genetic risk factor for Alzheimer’s Disease (AD). Meanwhile, many aspects of its impact on AD pathology remain underexplored. This study conducts a systematic data analysisof donor data from the Seattle Alzheimer’s Disease Brain Cell Atlas. Our investigation delves into the intricate interplay between identified biomarkers and their correlation with ApoE4 across all severities of AD. Employing Pearson R correlation, and one-way and two-way ANOVA tests, we elucidate the pathological changes in biomarkers and the altering effects of ApoE4. Remarkably, the phosphorylation of tau observed in neurofibrillary tangles (NFTs) marked by the AT8 antibody, emerges as the most correlated factor with other pathological biomarkers. This correlation is mediated by both tau and amyloid pathology, suggesting a higher hierarchical role in determining AD pathological effects than other biomarkers. However, non-ApoE4 carriers exhibit a more significant correlation with disease progression severity compared to ApoE4 carriers, though ApoE4 carriers demonstrate significance in exacerbating the effect of accumulating phosphorylated tau and amyloid plaques assessed by AT8 and 6E10 antibodies. Furthermore, our analysis does not observe dramatic neuronal changes in grey matter across the span of AD pathology. Glia activation, measured by Iba1 and GFAP, demonstrates an amyloid-specific correlation. This research marks the first human post-mortem analysis providing a comprehensive examination of prevailing AD biomarkers and their interconnectedness with pathology and ApoE4 genetic factor. Limitations in the study are acknowledged, underscoring the need for further exploration and refinement in future research endeavors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseApolipoprotein E4HumansBiomarkersPilot Projectstau ProteinsFemaleMaleAllelesAgedPhosphorylationNeurofibrillary TanglesBrainAged, 80 and overPlaque, AmyloidAutopsy

Substanzen

BiomarkersApolipoprotein E4tau Proteins

Autor:innen und Institutionen

  • Department of Internal Medicine, Gerontology and Geriatric Medicine, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.
  • Department of Translational Neuroscience, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.

ORCID-Profile: Ziyu Wan, Tao Ma

Förderung

  • NIA NIH HHS
  • National Institute on Aging

Zitieren

APA

Wan, Z., & Ma, T. (2025). The impact of apolipoprotein E, type ∊4 allele on Alzheimer’s disease pathological biomarkers: a comprehensive post-mortem pilot-analysis. PLOS ONE. https://doi.org/10.1371/journal.pone.0303486

Vancouver

Wan Z, Ma T. The impact of apolipoprotein E, type ∊4 allele on Alzheimer’s disease pathological biomarkers: a comprehensive post-mortem pilot-analysis. PLOS ONE. 2025. doi:10.1371/journal.pone.0303486

BibTeX
@article{Wan2025,
  author = {Wan, Ziyu and Ma, Tao},
  title = {The impact of apolipoprotein E, type ∊4 allele on Alzheimer’s disease pathological biomarkers: a comprehensive post-mortem pilot-analysis},
  journal = {PLOS ONE},
  year = {2025},
  doi = {10.1371/journal.pone.0303486}
}
Kostenlos starten →